Written answers
Thursday, 2 February 2017
Department of Health
Medicinal Products Availability
Shane Cassells (Meath West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
244. To ask the Minister for Health the measures he will put in place to reduce waiting times for multiple sclerosis sufferers who require assessment as responders to fampridine, based on a protocol provided by clinical experts; and if he will make a statement on the matter. [4984/17]
Shane Cassells (Meath West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
245. To ask the Minister for Health the measures he will put in place to expedite access to fampyra for multiple sclerosis sufferers identified as responders to fampridine; and if he will make a statement on the matter. [4985/17]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
I propose to take Questions Nos. 244 and 245 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments